Birgitte Volck

Biography

 Birgitte Volck, M.D., Ph.D., has served as a member of our board of directors since May 2016. Dr. Volck has served as head of Research and Development, Rare Diseases for GlaxoSmithKline plc since June 2016.  From 2012 to 2016, Dr. Volck was the Chief Medical Officer and Senior Vice President of Development at Swedish Orphan Biovitrum AB, a biopharmaceutical company.  From 2007 to 2012, Dr. Volck held various positions at Amgen Inc., a biopharmaceutical company, including Executive Development Director, Bone, Neuroscience & Inflammation.  Prior to Amgen, from 2004 to 2007, Dr. Volck served as Nordic Medical Director and Project Director at Genzyme A/S, a biotechnology company.  Dr. Volck received her M.D. and Ph.D. degrees from Copenhagen University, Denmark.

Research Interest

 MICROBIOLOGY